Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. 2007

Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
Diablo Clinical Research, 2255 Ygnacio Valley Rd., Suite M, Walnut Creek, CA 94598, USA. rweinstein@diabloclinical.com

OBJECTIVE The purpose of this study was to compare the accuracy of measurements of glucose in interstitial fluid made with the FreeStyle Navigator Continuous Glucose Monitoring System with Yellow Springs Instrument laboratory reference measurements of venous blood glucose. METHODS Fifty-eight subjects with type 1 diabetes, aged 18-64 years, were enrolled in a multicenter, prospective, single-arm study. Each subject wore two sensors simultaneously, which were calibrated with capillary fingerstick measurements at 10, 12, 24, and 72 h after insertion. Measurements from the FreeStyle Navigator system were collected at 1-min intervals and compared with venous measurements taken once every 15 min for 50 h over the 5-day period of sensor wear in an in-patient clinical research center. Periods of high rates of change of glucose were induced by insulin and glucose challenges. RESULTS Comparison of the FreeStyle Navigator measurements with the laboratory reference method (n = 20,362) gave mean and median absolute relative differences (ARDs) of 12.8 and 9.3%, respectively. The percentage in the clinically accurate Clarke error grid A zone was 81.7% and that in the in the benign error B zone was 16.7%. During low rates of change (< +/-1 mg x dl(-1) x min(-1)), the percentage in the A zone was higher (84.9%) and the mean and median ARDs were lower (11.7 and 8.5%, respectively). CONCLUSIONS Measurements with the FreeStyle Navigator system were found to be consistent and accurate compared with venous measurements made using a laboratory reference method over 5 days of sensor wear (82.5% in the A zone on day 1 and 80.9% on day 5).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
January 2007, Diabetes care,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
March 2009, Diabetes technology & therapeutics,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
August 2004, Diabetes care,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
January 2011, Journal of diabetes science and technology,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
September 2009, Journal of diabetes science and technology,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
February 2009, Diabetes technology & therapeutics,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
November 2017, Diabetes technology & therapeutics,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
June 2021, American family physician,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
August 2023, Diabetes technology & therapeutics,
Richard L Weinstein, and Sherwyn L Schwartz, and Ronald L Brazg, and Jolyon R Bugler, and Thomas A Peyser, and Geoffrey V McGarraugh
April 2023, Diabetes therapy : research, treatment and education of diabetes and related disorders,
Copied contents to your clipboard!